N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as DDP-IV inhibitors

Details for Australian Patent Application No. 2003209514 (hide)

International Classifications

Event Publications

17 July 2003 Complete Application Filed

Priority application(s): P 0200849 06.03.02 HU

23 October 2003 Application Open to Public Inspection

Published as AU-B-2003209514

13 January 2005 Assignment before Grant

Sanofi-Synthelabo The application has been assigned to Sanofi-Aventis

17 February 2005 Change of Name(s) of Applicant(s), Section 104

Sanofi-Synthelabo The name of the applicant has been changed to Sanofi-Aventis

16 July 2009 Application Accepted

Published as AU-B-2003209514

12 November 2009 Standard Patent Sealed

27 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.